Top

Published in:

01-11-2020 | Ultrasound | Special Section: Diffuse Liver Disease

Imaging biomarkers of diffuse liver disease: current status

Authors: Bachir Taouli, Filipe Caseiro Alves

Published in: Abdominal Radiology | Issue 11/2020

Abstract

We are happy to introduce this special issue of Abdominal Radiology on “diffuse liver disease”. We have invited imaging experts to discuss various topics pertaining to diffuse liver disease, covering a vast array of imaging techniques including ultrasound (US), CT, MRI and new molecular imaging agents. Below, we briefly discussed the current status, limitations, and future directions of imaging biomarkers of diffuse liver disease.

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018). Lancet 392 (10159):1789–1858. https://doi.org/10.1016/S0140-6736(18)32279-7

Moon AM, Singal AG, Tapper EB (2019) Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. Clin Gastroenterol Hepatol. https://doi.org/10.1016/j.cgh.2019.07.060CrossRefPubMed

Asrani SK, Devarbhavi H, Eaton J, Kamath PS (2019) Burden of liver diseases in the world. J Hepatol 70 (1):151-171. https://doi.org/10.1016/j.jhep.2018.09.014CrossRefPubMed

Goodman ZD (2007) Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol 47 (4):598-607. https://doi.org/10.1016/j.jhep.2007.07.006CrossRefPubMed

Bedossa P, Dargere D, Paradis V (2003) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38 (6):1449-1457CrossRef

Poynard T, Imbert-Bismut F, Munteanu M, Ratziu V (2005) FibroTest-FibroSURE: towards a universal biomarker of liver fibrosis? Expert Rev Mol Diagn 5 (1):15-21CrossRef

El-Badry AM, Breitenstein S, Jochum W, Washington K, Paradis V, Rubbia-Brandt L, Puhan MA, Slankamenac K, Graf R, Clavien PA (2009) Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 250 (5):691-697. doi:10.1097/SLA.0b013e3181bcd6ddhttps://doi.org/10.1097/SLA.0b013e3181bcd6ddCrossRefPubMed

Castéra L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Darriet M, Couzigou P, de Lédinghen V (2005) Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2):343-350. doi:10.1053/j.gastro.2004.11.018https://doi.org/10.1053/j.gastro.2004.11.018CrossRefPubMed

Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, de Ledinghen V, Marcellin P, Dhumeaux D, Trinchet JC, Beaugrand M (2005) Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41 (1):48-54CrossRef

10.

Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X, Bertet J, Couzigou P, de Ledinghen V (2006) Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 55 (3):403-408. https://doi.org/10.1136/gut.2005.069153CrossRefPubMedPubMedCentral

11.

Castera L, Forns X, Alberti A (2008) Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 48 (5):835-847. https://doi.org/10.1016/j.jhep.2008.02.008CrossRefPubMed

12.

Friedrich-Rust M, Wunder K, Kriener S, Sotoudeh F, Richter S, Bojunga J, Herrmann E, Poynard T, Dietrich CF, Vermehren J, Zeuzem S, Sarrazin C (2009) Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology 252 (2):595-604. doi: 10.1148/radiol.2523081928https://doi.org/10.1148/radiol.2523081928CrossRefPubMed

13.

Sporea I, Sirli R, Bota S, Popescu A, Sendroiu M, Jurchis A (2012) Comparative Study Concerning the Value of Acoustic Radiation Force Impulse Elastography (ARFI) in Comparison with Transient Elastography (TE) for the Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B and C. Ultrasound in Medicine & Biology 38 (8):1310-1316. doi:10.1016/j.ultrasmedbio.2012.03.011https://doi.org/10.1016/j.ultrasmedbio.2012.03.011CrossRef

14.

Ferraioli G, Tinelli C, Dal Bello B, Zicchetti M, Filice G, Filice C, on behalf of the Liver Fibrosis Study G (2012) Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: A pilot study. Hepatology 56 (6):2125-2133. https://doi.org/10.1002/hep.25936

15.

Leung VY-f, Shen J, Wong VW-s, Abrigo J, Wong GL-h, Chim AM-l, Chu SH-t, Chan AW-h, Choi PC-l, Ahuja AT, Chan HL-y, Chu WC-w (2013) Quantitative Elastography of Liver Fibrosis and Spleen Stiffness in Chronic Hepatitis B Carriers: Comparison of Shear-Wave Elastography and Transient Elastography with Liver Biopsy Correlation. Radiology 269 (3):910-918. https://doi.org/10.1148/radiol.13130128

16.

Yin M, Talwalkar JA, Glaser KJ, Manduca A, Grimm RC, Rossman PJ, Fidler JL, Ehman RL (2007) Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 5 (10):1207–1213 e1202

17.

Yin M, Glaser KJ, Talwalkar JA, Chen J, Manduca A, Ehman RL (2016) Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations. Radiology 278 (1):114-124. https://doi.org/10.1148/radiol.2015142141CrossRefPubMed

18.

Kennedy P, Wagner M, Castera L, Hong CW, Johnson CL, Sirlin CB, Taouli B (2018) Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions. Radiology 286 (3):738-763. https://doi.org/10.1148/radiol.2018170601CrossRefPubMedPubMedCentral

19.

Salkic NN, Jovanovic P, Hauser G, Brcic M (2014) FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis. Am J Gastroenterol 109 (6):796-809. https://doi.org/10.1038/ajg.2014.21CrossRefPubMed

20.

Lichtinghagen R, Pietsch D, Bantel H, Manns MP, Brand K, Bahr MJ (2013) The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values. J Hepatol 59 (2):236-242. https://doi.org/10.1016/j.jhep.2013.03.016CrossRefPubMed

21.

Xiao G, Zhu S, Xiao X, Yan L, Yang J, Wu G (2017) Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis. Hepatology 66 (5):1486-1501. https://doi.org/10.1002/hep.29302CrossRefPubMed

22.

Tada T, Kumada T, Toyoda H, Sone Y, Takeshima K, Ogawa S, Goto T, Wakahata A, Nakashima M, Nakamuta M, Tanaka J (2018) Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct-acting anti-viral therapy. Aliment Pharmacol Ther 47 (7):1012-1022. https://doi.org/10.1111/apt.14554CrossRefPubMed

23.

Elsharkawy A, Abdel Alem S, Fouad R, El Raziky M, El Akel W, Abdo M, Tantawi O, AbdAllah M, Bourliere M, Esmat G (2017) Changes in Liver stiffness measurements and Fibrosis scores following Sofosbuvir based treatment regimens without Interferon. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.13758CrossRefPubMed

24.

Dyvorne HA, Jajamovich GH, Bane O, Fiel MI, Chou H, Schiano TD, Dieterich D, Babb JS, Friedman SL, Taouli B (2016) Prospective comparison of magnetic resonance imaging to transient elastography and serum markers for liver fibrosis detection. Liver Int 36 (5):659-666. https://doi.org/10.1111/liv.13058CrossRefPubMedPubMedCentral

25.

Wang Y, Ganger DR, Levitsky J, Sternick LA, McCarthy RJ, Chen ZE, Fasanati CW, Bolster B, Shah S, Zuehlsdorff S, Omary RA, Ehman RL, Miller FH (2011) Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol 196 (3):553-561. https://doi.org/10.2214/AJR.10.4580CrossRefPubMedPubMedCentral

26.

Myers RP, Pomier-Layrargues G, Kirsch R, Pollett A, Duarte-Rojo A, Wong D, Beaton M, Levstik M, Crotty P, Elkashab M (2012) Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 55 (1):199-208. https://doi.org/10.1002/hep.24624CrossRefPubMed

27.

Wagner M, Corcuera-Solano I, Lo G, Esses S, Liao J, Besa C, Chen N, Abraham G, Fung M, Babb JS, Ehman RL, Taouli B (2017) Technical Failure of MR Elastography Examinations of the Liver: Experience from a Large Single-Center Study. Radiology:160863. https://doi.org/10.1148/radiol.2016160863

28.

Ghoz HM, Kroner PT, Stancampiano FF, Bowman AW, Vishnu P, Heckman MG, Diehl NN, McLeod E, Nikpour N, Palmer WC (2019) Hepatic iron overload identified by magnetic resonance imaging-based T2* is a predictor of non-diagnostic elastography. Quantitative imaging in medicine and surgery 9 (6):921-927. https://doi.org/10.21037/qims.2019.05.13CrossRefPubMedPubMedCentral

29.

Wagner M, Besa C, Bou Ayache J, Yasar TK, Bane O, Fung M, Ehman RL, Taouli B (2016) Magnetic Resonance Elastography of the Liver: Qualitative and Quantitative Comparison of Gradient Echo and Spin Echo Echoplanar Imaging Sequences. Invest Radiol. https://doi.org/10.1097/RLI.0000000000000269CrossRefPubMedPubMedCentral

30.

Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder SB (2008) Multiecho Water-Fat Separation and Simultaneous R*2 Estimation With Multifrequency Fat Spectrum Modeling. Magnetic Resonance in Medicine 60:1122–1134CrossRef

31.

Meisamy S, Hines CD, Hamilton G, Sirlin CB, McKenzie CA, Yu H, Brittain JH, Reeder SB (2011) Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 258 (3):767-775. https://doi.org/10.1148/radiol.10100708CrossRefPubMedPubMedCentral

32.

Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, Fujita K, Yoneda M, Taguri M, Hyogo H, Sumida Y, Ono M, Eguchi Y, Inoue T, Yamanaka T, Wada K, Saito S, Nakajima A (2016) Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. Gastroenterology 150 (3):626–637 e627. https://doi.org/10.1053/j.gastro.2015.11.048

33.

Caussy C, Reeder SB, Sirlin CB, Loomba R (2018) Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials. Hepatology 68 (2):763-772. https://doi.org/10.1002/hep.29797CrossRefPubMedPubMedCentral

34.

Dulai PS, Sirlin CB, Loomba R (2016) MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice. J Hepatol 65 (5):1006-1016. https://doi.org/10.1016/j.jhep.2016.06.005CrossRefPubMedPubMedCentral

35.

St Pierre TG, Clark PR, Chua-anusorn W, Fleming AJ, Jeffrey GP, Olynyk JK, Pootrakul P, Robins E, Lindeman R (2005) Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 105 (2):855-861CrossRef

36.

Gandon Y, Olivie D, Guyader D, Aube C, Oberti F, Sebille V, Deugnier Y (2004) Non-invasive assessment of hepatic iron stores by MRI. Lancet 363 (9406):357-362CrossRef

37.

Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD (2005) MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 106 (4):1460-1465CrossRef

38.

d'Assignies G, Paisant A, Bardou-Jacquet E, Boulic A, Bannier E, Laine F, Ropert M, Morcet J, Saint-Jalmes H, Gandon Y (2018) Non-invasive measurement of liver iron concentration using 3-Tesla magnetic resonance imaging: validation against biopsy. Eur Radiol 28 (5):2022-2030. https://doi.org/10.1007/s00330-017-5106-3CrossRefPubMed

39.

Hoad CL, Palaniyappan N, Kaye P, Chernova Y, James MW, Costigan C, Austin A, Marciani L, Gowland PA, Guha IN, Francis ST, Aithal GP (2015) A study of T(1) relaxation time as a measure of liver fibrosis and the influence of confounding histological factors. NMR Biomed 28 (6):706-714. https://doi.org/10.1002/nbm.3299CrossRefPubMed

40.

Heye T, Yang SR, Bock M, Brost S, Weigand K, Longerich T, Kauczor HU, Hosch W (2012) MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis. Eur Radiol 22 (6):1224-1232. https://doi.org/10.1007/s00330-012-2378-5CrossRefPubMed

41.

Cassinotto C, Feldis M, Vergniol J, Mouries A, Cochet H, Lapuyade B, Hocquelet A, Juanola E, Foucher J, Laurent F, De Ledinghen V (2015) MR relaxometry in chronic liver diseases: Comparison of T1 mapping, T2 mapping, and diffusion-weighted imaging for assessing cirrhosis diagnosis and severity. Eur J Radiol 84 (8):1459-1465. https://doi.org/10.1016/j.ejrad.2015.05.019CrossRefPubMed

42.

Pavlides M, Banerjee R, Sellwood J, Kelly CJ, Robson MD, Booth JC, Collier J, Neubauer S, Barnes E (2016) Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease. J Hepatol 64 (2):308-315. https://doi.org/10.1016/j.jhep.2015.10.009CrossRefPubMedPubMedCentral

43.

Haimerl M, Utpatel K, Verloh N, Zeman F, Fellner C, Nickel D, Teufel A, Fichtner-Feigl S, Evert M, Stroszczynski C, Wiggermann P (2017) Gd-EOB-DTPA-enhanced MR relaxometry for the detection and staging of liver fibrosis. Scientific reports 7:41429. https://doi.org/10.1038/srep41429CrossRefPubMedPubMedCentral

44.

Bastati N, Beer L, Mandorfer M, Poetter-Lang S, Tamandl D, Bican Y, Elmer MC, Einspieler H, Semmler G, Simbrunner B, Weber M, Hodge JC, Vernuccio F, Sirlin C, Reiberger T, Ba-Ssalamah A (2020) Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease? Radiology 294 (1):98-107. https://doi.org/10.1148/radiol.2019190734CrossRefPubMed

45.

Bastati N, Feier D, Wibmer A, Traussnigg S, Balassy C, Tamandl D, Einspieler H, Wrba F, Trauner M, Herold C, Ba-Ssalamah A (2014) Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid-enhanced MR imaging in patients with nonalcoholic fatty liver disease: a proof-of-concept study. Radiology 271 (3):739-747. https://doi.org/10.1148/radiol.14131890CrossRefPubMed

46.

Feier D, Balassy C, Bastati N, Fragner R, Wrba F, Ba-Ssalamah A (2016) The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis--a multiparametric approach. Eur Radiol 26 (2):539-546. https://doi.org/10.1007/s00330-015-3830-0CrossRefPubMed

47.

Ba-Ssalamah A, Bastati N, Wibmer A, Fragner R, Hodge JC, Trauner M, Herold CJ, Bashir MR, Van Beers BE (2017) Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we? J Magn Reson Imaging 45 (3):646-659. https://doi.org/10.1002/jmri.25518CrossRefPubMed

48.

Chen Y, Jiang Y, Pahwa S, Ma D, Lu L, Twieg MD, Wright KL, Seiberlich N, Griswold MA, Gulani V (2016) MR Fingerprinting for Rapid Quantitative Abdominal Imaging. Radiology 279 (1):278-286. https://doi.org/10.1148/radiol.2016152037CrossRefPubMedPubMedCentral

49.

Feng L, Axel L, Chandarana H, Block KT, Sodickson DK, Otazo R (2016) XD-GRASP: Golden-angle radial MRI with reconstruction of extra motion-state dimensions using compressed sensing. Magn Reson Med 75 (2):775-788. https://doi.org/10.1002/mrm.25665CrossRefPubMed

50.

Mansour R, Thibodeau Antonacci A, Bilodeau L, Vazquez Romaguera L, Cerny M, Huet C, Gilbert G, Tang A, Kadoury S (2020) Impact of temporal resolution and motion correction for dynamic contrast-enhanced MRI of the liver using an accelerated golden-angle radial sequence. Phys Med Biol 65 (8):085004. https://doi.org/10.1088/1361-6560/ab78beCrossRefPubMed

51.

Weiss J, Ruff C, Grosse U, Grozinger G, Horger M, Nikolaou K, Gatidis S (2019) Assessment of Hepatic Perfusion Using GRASP MRI: Bringing Liver MRI on a New Level. Invest Radiol 54 (12):737-743. https://doi.org/10.1097/RLI.0000000000000586CrossRefPubMed

52.

Pahwa S, Liu H, Chen Y, Dastmalchian S, O'Connor G, Lu Z, Badve C, Yu A, Wright K, Chalian H, Rao S, Fu C, Vallines I, Griswold M, Seiberlich N, Zeng M, Gulani V (2018) Quantitative perfusion imaging of neoplastic liver lesions: A multi-institution study. Scientific reports 8 (1):4990. https://doi.org/10.1038/s41598-018-20726-1CrossRefPubMedPubMedCentral

53.

Bane O, Peti S, Wagner M, Hectors S, Dyvorne H, Markl M, Taouli B (2019) Hemodynamic measurements with an abdominal 4D flow MRI sequence with spiral sampling and compressed sensing in patients with chronic liver disease. J Magn Reson Imaging 49 (4):994-1005. https://doi.org/10.1002/jmri.26305CrossRefPubMed

54.

Dyvorne H, Knight-Greenfield A, Jajamovich G, Besa C, Cui Y, Stalder A, Markl M, Taouli B (2015) Abdominal 4D flow MR imaging in a breath hold: combination of spiral sampling and dynamic compressed sensing for highly accelerated acquisition. Radiology 275 (1):245-254. https://doi.org/10.1148/radiol.14140973CrossRefPubMed

55.

Motosugi U, Roldan-Alzate A, Bannas P, Said A, Kelly S, Zea R, Wieben O, Reeder SB (2019) Four-dimensional Flow MRI as a Marker for Risk Stratification of Gastroesophageal Varices in Patients with Liver Cirrhosis. Radiology 290 (1):101-107. https://doi.org/10.1148/radiol.2018180230CrossRefPubMed

56.

Roldan-Alzate A, Frydrychowicz A, Niespodzany E, Landgraf BR, Johnson KM, Wieben O, Reeder SB (2013) In vivo validation of 4D flow MRI for assessing the hemodynamics of portal hypertension. J Magn Reson Imaging 37 (5):1100-1108.https://doi.org/10.1002/jmri.23906CrossRefPubMed

57.

Lubner MG, Malecki K, Kloke J, Ganeshan B, Pickhardt PJ (2017) Texture analysis of the liver at MDCT for assessing hepatic fibrosis. Abdom Radiol (NY) 42 (8):2069-2078. https://doi.org/10.1007/s00261-017-1096-5CrossRef

58.

Naganawa S, Enooku K, Tateishi R, Akai H, Yasaka K, Shibahara J, Ushiku T, Abe O, Ohtomo K, Kiryu S (2018) Imaging prediction of nonalcoholic steatohepatitis using computed tomography texture analysis. Eur Radiol 28 (7):3050-3058. https://doi.org/10.1007/s00330-017-5270-5CrossRefPubMed

59.

Cannella R, Borhani AA, Tublin M, Behari J, Furlan A (2019) Diagnostic value of MR-based texture analysis for the assessment of hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). Abdom Radiol (NY) 44 (5):1816-1824. https://doi.org/10.1007/s00261-019-01931-6CrossRefPubMed

60.

Schawkat K, Ciritsis A, von Ulmenstein S, Honcharova-Biletska H, Jungst C, Weber A, Gubler C, Mertens J, Reiner CS (2020) Diagnostic accuracy of texture analysis and machine learning for quantification of liver fibrosis in MRI: correlation with MR elastography and histopathology. Eur Radiol. https://doi.org/10.1007/s00330-020-06831-8CrossRefPubMed

61.

Choi KJ, Jang JK, Lee SS, Sung YS, Shim WH, Kim HS, Yun J, Choi JY, Lee Y, Kang BK, Kim JH, Kim SY, Yu ES (2018) Development and Validation of a Deep Learning System for Staging Liver Fibrosis by Using Contrast Agent-enhanced CT Images in the Liver. Radiology 289 (3):688-697. https://doi.org/10.1148/radiol.2018180763CrossRefPubMed

62.

Liu Y, Ning Z, Ormeci N, An W, Yu Q, Han K, Huang Y, Liu D, Liu F, Li Z, Ding H, Luo H, Zuo C, Liu C, Wang J, Zhang C, Ji J, Wang W, Wang Z, Wang W, Yuan M, Li L, Zhao Z, Wang G, Li M, Liu Q, Lei J, Liu C, Tang T, Akcalar S, Celebioglu E, Ustuner E, Bilgic S, Ellik Z, Asiller OO, Liu Z, Teng G, Chen Y, Hou J, Li X, He X, Dong J, Tian J, Liang P, Ju S, Zhang Y, Qi X (2020) Deep Convolutional Neural Network-aided Detection of Portal Hypertension in Patients With Cirrhosis. Clin Gastroenterol Hepatol. https://doi.org/10.1016/j.cgh.2020.03.034CrossRefPubMedPubMedCentral

63.

Wang K, Lu X, Zhou H, Gao Y, Zheng J, Tong M, Wu C, Liu C, Huang L, Jiang T, Meng F, Lu Y, Ai H, Xie XY, Yin LP, Liang P, Tian J, Zheng R (2019) Deep learning Radiomics of shear wave elastography significantly improved diagnostic performance for assessing liver fibrosis in chronic hepatitis B: a prospective multicentre study. Gut 68 (4):729-741. https://doi.org/10.1136/gutjnl-2018-316204CrossRefPubMed

64.

Farrar CT, Gale EM, Kennan R, Ramsay I, Masia R, Arora G, Looby K, Wei L, Kalpathy-Cramer J, Bunzel MM, Zhang C, Zhu Y, Akiyama TE, Klimas M, Pinto S, Diyabalanage H, Tanabe KK, Humblet V, Fuchs BC, Caravan P (2018) CM-101: Type I Collagen-targeted MR Imaging Probe for Detection of Liver Fibrosis. Radiology 287 (2):581-589. https://doi.org/10.1148/radiol.2017170595CrossRefPubMed

65.

Salarian M, Turaga RC, Xue S, Nezafati M, Hekmatyar K, Qiao J, Zhang Y, Tan S, Ibhagui OY, Hai Y, Li J, Mukkavilli R, Sharma M, Mittal P, Min X, Keilholz S, Yu L, Qin G, Farris AB, Liu ZR, Yang JJ (2019) Early detection and staging of chronic liver diseases with a protein MRI contrast agent. Nature communications 10 (1):4777. https://doi.org/10.1038/s41467-019-11984-2CrossRefPubMedPubMedCentral

66.

Cunha GM, Villela-Nogueira CA, Bergman A, Lobo Lopes FPP (2018) Abbreviated mpMRI protocol for diffuse liver disease: a practical approach for evaluation and follow-up of NAFLD. Abdom Radiol (NY) 43 (9):2340-2350. https://doi.org/10.1007/s00261-018-1504-5CrossRef

67.

Besa C, Lewis S, Pandharipande PV, Chhatwal J, Kamath A, Cooper N, Knight-Greenfield A, Babb JS, Boffetta P, Padron N, Sirlin CB, Taouli B (2017) Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid. Abdom Radiol (NY) 42 (1):179-190. https://doi.org/10.1007/s00261-016-0841-5CrossRef

68.

Marks RM, Ryan A, Heba ER, Tang A, Wolfson TJ, Gamst AC, Sirlin CB, Bashir MR (2015) Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance. AJR Am J Roentgenol 204 (3):527-535. https://doi.org/10.2214/AJR.14.12986CrossRefPubMed

69.

Vietti Violi N, Lewis S, Liao J, Hulkower M, Hernandez-Meza G, Smith K, Babb JS, Chin X, Song J, Said D, Kihira S, Sirlin CB, Reeder SB, Bashir MR, Fowler KJ, Ferket BS, Sigel K, Taouli B. Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening. Eur Radiol (in press)

Title: Imaging biomarkers of diffuse liver disease: current status
Authors: Bachir Taouli
Filipe Caseiro Alves
Publication date: 01-11-2020
Publisher: Springer US
Keywords: Ultrasound
Ultrasound
Biomarkers
Published in: Abdominal Radiology / Issue 11/2020
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-020-02619-y

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Imaging biomarkers of diffuse liver disease: current status

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2020

Diagnostic performance of the LR-M criteria and spectrum of LI-RADS imaging features among primary hepatic carcinomas

Relationship between magnetic resonance imaging spleen T1 relaxation and other radiologic and clinical biomarkers of liver fibrosis in children and young adults with autoimmune liver disease

Fournier gangrene: pictorial review

Noninvasive imaging assessment of portal hypertension

Magnetic Resonance imaging analysis of liver fibrosis and inflammation: overwhelming gray zones restrict clinical use

Transjugular intrahepatic portosystemic shunt placement: portal vein puncture guided by 3D/2D image registration of contrast-enhanced multi-detector computed tomography and fluoroscopy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page